Simplex Trading
HUMA icon

Simplex Trading’s Humacyte HUMA Stock Holding History

Simplex Trading’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-96,175
Closed -$361K – 8969
2024
Q4 		$485K Sell
96,175
-34,532
-26% -$171K ﹤0.01% 3570
2024
Q3 		$711K Buy
130,707
+61,690
+89% +$407K ﹤0.01% 3240
2024
Q2 		$331K Buy
69,017
+38,605
+127% +$201K ﹤0.01% 4113
2024
Q1 		$94K Buy
30,412
+10,419
+52% +$35K ﹤0.01% 5650
2023
Q4 		$56K Buy
19,993
+9,752
+95% +$25K ﹤0.01% 5975
2023
Q3 		$30K Buy
10,241
+6,267
+158% +$20.7K ﹤0.01% 6254
2023
Q2 		$11K Buy
+3,974
New +$14.3K ﹤0.01% 7313
2023
Q1 		– Sell
-3,171
Closed -$9.02K – 9474
2022
Q4 		$6K Sell
3,171
-37,554
-92% -$114K ﹤0.01% 7928
2022
Q3 		$132K Buy
+40,725
New +$156K ﹤0.01% 5145
2022
Q2 		– Sell
-33,351
Closed -$185K – 10421
2022
Q1 		$235K Buy
33,351
+18,148
+119% +$106K ﹤0.01% 4924
2021
Q4 		$110K Buy
+15,203
New +$150K ﹤0.01% 6097

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Simplex Trading's HUMA Position: Q1 2025 in Review

Simplex Trading sold out of Humacyte (HUMA) in Q1 2025, closing a stake of 96,175 shares — an estimated $361K sold.

Simplex Trading first reported a position in HUMA in Q4 2021 and held it in 11 quarters. The position peaked at $711K in Q3 2024. 168 funds tracked by Wall St. Rank hold HUMA as of Q1 2025.

  • Simplex Trading reported no remaining Humacyte position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 96,175 Humacyte shares in Q1 2025, an estimated $361K.
  • Simplex Trading first reported a position in Humacyte in Q4 2021 and held it in 11 quarters.
  • Simplex Trading's Humacyte position peaked at $711K in Q3 2024.
  • 168 funds tracked by Wall St. Rank held Humacyte as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.